Novavax CEO to Present at BIO CEO & Investor Conference

ROCKVILLE, Md., Feb. 6 Novavax, Inc.(Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr.Rahul Singhvi, President and Chief Executive Officer, will be presenting atthe BIO CEO & Investor Conference at 1:15 p.m. on February 12, 2008 at theWaldorf=Astoria Hotel in New York. Dr. Singhvi will provide an overview ofthe company's strategy, research and development progress. A link to the livepresentation can be accessed via the Company website at www.novavax.com. Anarchive of the presentation will be available one hour after the event on theNovavax website for 90 days.

ABOUT NOVAVAX

Novavax Inc. is committed to leading the global fight against infectiousdisease by creating novel, highly potent vaccines that are safer and moreeffective than current preventive options. Using the company's proprietaryvirus-like particle (VLP) and Novasome(R) adjuvant technologies, Novavax isdeveloping vaccines to protect against H5N1 pandemic influenza, seasonal fluand other viral diseases. Novavax's particulate vaccines closely matchdisease-causing viruses while lacking the genetic material to cause disease,which provides potential for greater immune protection at lower doses thancurrent vaccines. With an exclusive portable manufacturing system that allowsfor rapid mass-production of vaccines, Novavax is uniquely positioned to meetglobal public health needs.

SOURCE Novavax, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...